Logo
x

Search

Subscribe Now

Submit

Gilead Plans to Submit MAA to CDSCO for its Remdesivir to Treat COVID-19 in India

Gilead Plans to Submit MAA to CDSCO for its Remdesivir to Treat COVID-19 in India

  • May 22, 2020
Celgene and Acceleron Pharma Submit Biologics License Application (BLA) to the US FDA for Luspatercept

Celgene and Acceleron Pharma Submit Biologics License Application (BLA) to the US FDA for Luspatercept

  • April 8, 2019
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.